melanocortin agonistMelanocortin PeptidesVerified Match
PT-141 (Bremelanotide)
A cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. FDA-approved (Vyleesi) for hypoactive sexual desire disorder in premenopausal women. Acts centrally on MC4R in the brain.
sexual-functionlibido-enhancementmelanocortin-agonistFDA-approved
Best vendor: Pure Health Peptides
Lab Tested
Yes
Harmful Ingredients
0
Contaminants
None
Tested Purity
99.9%
Batch Consistency
UNKNOWNTUY-030926-HC1
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch#UNKNOWN
Total Tests42
Unique Vendors28
Vendor Comparison
| Vendor | Status |
|---|---|
P Pure Health Peptides | Pending |
P Pure Health Peptides | Pending |
P Pure Health Peptides | Pending |
P Pure Health Peptides | Pending |
P Pure Health Peptides | Verified |
Analysis Summary
Purity Standard
Passes (≥98%) — 99.9%
Lab Reports
42 reports on file
Summary
A cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. FDA-approved (Vyleesi) for hypoactive sexual desire disorder in premenopausal women. Acts centrally on MC4R in the brain.